Unknown PHASE2 INTERVENTIONAL 1-arm NCT02632864

Feasibility of High Dose PROton Therapy On Unresectable Primary Carcinoma Of Liver: Prospective Phase II Trial

Sponsor: Samsung Medical Center

Conditions Liver Neoplasm Proton Therapy

Interventions Proton arm

Updated 8 times since 2017 Last updated: Apr 11, 2018 Started: Dec 31, 2015 Primary completion: Oct 31, 2019 Completion: Nov 30, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Liver Neoplasm and Proton Therapy, this trial is ongoing. The trial is conducted by Samsung Medical Center and has accumulated 8 data snapshots since 2015. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE2
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Dec 2022 — Jul 2024 [monthly]

Unknown Status PHASE2

Status: Recruiting → Unknown Status
Jan 2021 — Dec 2022 [monthly]

Recruiting PHASE2

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Recruiting PHASE2
May 2018 — Jun 2018 [monthly]

Recruiting PHASE2
Jan 2017 — May 2018 [monthly]

Recruiting PHASE2

First recorded

Dec 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Samsung Medical Center

Data source: Samsung Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea